Mehmet Oz, President Donald Trump’s nominee to lead Medicare and Medicaid, told senators he would focus on chronic disease ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health jumped 3.1% in the last session, extending its six-day rally. The surge was fueled by investor optimism, a ...

Elevance Health ELV -2.57% + Free Alerts has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

March 10, 2025 • At First Corinthian Baptist Church in Harlem, New York, a therapist was fielding 10 calls a week from parents of teens who needed mental health help. Now the church is part of a ...

Clover's AI capabilities drive revenue growth and efficiency, setting the stage for future profitability. Read here to know ...